Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Change in Acquisitions & Divestments: 2023-2024

Historic Change in Acquisitions & Divestments for Orchestra BioMed Holdings (OBIO) over the last 2 years, with Dec 2024 value amounting to $86.6 million.

  • Orchestra BioMed Holdings' Change in Acquisitions & Divestments fell 10.42% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.1 million, marking a year-over-year decrease of 44.48%. This contributed to the annual value of $86.6 million for FY2024, which is 43.31% down from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Change in Acquisitions & Divestments stood at $86.6 million for FY2024, which was down 43.31% from $152.8 million recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Change in Acquisitions & Divestments ranged from a high of $152.8 million in FY2023 and a low of $86.6 million during FY2024.
  • Over the past 2 years, Orchestra BioMed Holdings' median Change in Acquisitions & Divestments value was $119.7 million (recorded in 2023), while the average stood at $119.7 million.
  • Data for Orchestra BioMed Holdings' Change in Acquisitions & Divestments shows a maximum YoY slumped of 43.31% (in 2024) over the last 5 years.
  • Orchestra BioMed Holdings' Change in Acquisitions & Divestments (Yearly) stood at $152.8 million in 2023, then tumbled by 43.31% to $86.6 million in 2024.